BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.
Level 5 - mechanism / opinion, no new human data
Narrative review discussing imaging and clinical management without systematic review methodology or primary data
PubMed 28548905 · doi:10.1148/rg.2017160144
What was done
The authors conducted a narrative review describing the etiopathogenesis, clinical and pathologic characteristics, and imaging findings associated with BRCA gene mutations across various malignancies (primarily breast and ovarian cancers, but also fallopian tube, primary peritoneal, pancreatic, prostate, and colon cancers). The article discusses screening recommendations, diagnostic approaches, and multidisciplinary management strategies for mutation carriers.
What was found
The abstract does not provide quantitative data, specific sensitivity/specificity values for imaging modalities, or comparative statistics. It summarizes that BRCA-associated cancers are characterized by early onset, high tumor grade, and aggressive clinical courses compared to sporadic tumors, emphasizing that supplemental early screening and surveillance via imaging are essential components of management.
Why it matters
Understanding the unique imaging features and aggressive natural history of BRCA-associated malignancies helps radiologists and multidisciplinary teams implement appropriate early screening, accurate staging, and tailored management protocols in high-risk patients.
Limits
The abstract describes a broad narrative educational review without systematic literature search criteria, meta-analytic synthesis, or original clinical trial data. Quantitative diagnostic metrics, specific imaging protocols, and comparative outcomes between modalities are not reported in the abstract.
Cited by
- supports BRCA mutations account for only a small minority of overall cancers, but confer a very high individual lifetime cancer risk to carriers.